- Home
- MVBF vs CMPX Comparison
MVBF vs CMPX Comparison
Compare MVBF & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVBF
- CMPX
- Stock Information
- Founded
- MVBF 1997
- CMPX 2014
- Country
- MVBF United States
- CMPX United States
- Employees
- MVBF N/A
- CMPX N/A
- Industry
- MVBF Major Banks
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- MVBF Finance
- CMPX Health Care
- Exchange
- MVBF Nasdaq
- CMPX Nasdaq
- Market Cap
- MVBF 282.7M
- CMPX 291.8M
- IPO Year
- MVBF N/A
- CMPX N/A
- Fundamental
- Price
- MVBF $24.04
- CMPX $3.44
- Analyst Decision
- MVBF Buy
- CMPX Strong Buy
- Analyst Count
- MVBF 4
- CMPX 8
- Target Price
- MVBF $24.50
- CMPX $13.50
- AVG Volume (30 Days)
- MVBF 42.4K
- CMPX 1.4M
- Earning Date
- MVBF 10-29-2025
- CMPX 08-11-2025
- Dividend Yield
- MVBF 2.83%
- CMPX N/A
- EPS Growth
- MVBF N/A
- CMPX N/A
- EPS
- MVBF 1.29
- CMPX N/A
- Revenue
- MVBF $143,378,000.00
- CMPX N/A
- Revenue This Year
- MVBF N/A
- CMPX N/A
- Revenue Next Year
- MVBF $15.28
- CMPX N/A
- P/E Ratio
- MVBF $18.64
- CMPX N/A
- Revenue Growth
- MVBF N/A
- CMPX N/A
- 52 Week Low
- MVBF $15.59
- CMPX $1.27
- 52 Week High
- MVBF $25.13
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- MVBF 57.46
- CMPX 62.85
- Support Level
- MVBF $23.73
- CMPX $3.29
- Resistance Level
- MVBF $24.45
- CMPX $3.52
- Average True Range (ATR)
- MVBF 0.47
- CMPX 0.18
- MACD
- MVBF 0.04
- CMPX 0.04
- Stochastic Oscillator
- MVBF 74.38
- CMPX 81.68
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.